| Trial ID: | L6998 |
| Source ID: | NCT00541697
|
| Associated Drug: |
Mk0653a, Ezetimibe (+) Simvastatin / Duration Of Treatment: 6 Weeks
|
| Title: |
Eze/Simva Switch Study in Diabetics (0653A-807)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks|DRUG: Comparator: atorvastatin / Duration of Treatment: 6 Weeks
|
| Outcome Measures: |
Primary: Determine the additional LDL-C lowering achieved by switching to MK0653A as compared to Atorvastatin after 6 weeks of treatment, 6 Weeks | Secondary: Determine the effect of MK0653A versus Atorvastatin on total cholesterol after 6 weeks of treatment, 6 Weeks
|
| Sponsor/Collaborators: |
Sponsor: Organon and Co
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
648
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-01-19
|
| Completion Date: |
2005-10-14
|
| Results First Posted: |
|
| Last Update Posted: |
2024-08-15
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00541697
|
